Zacks Investment Research on MSN
Should You Buy, Sell or Hold J&J Stock After Robust Q3 Earnings?
Johnson & Johnson JNJ delivered strong third-quarter 2025 results, with both the top and bottom lines exceeding expectations.
A nurse from LeClaire was the first lung-surgery patient to undergo a new procedure at Northwestern Medicine in Chicago.
Qureight, a techbio company advancing the understanding of lung and heart disease through application of its AI-powered ...
New research from UCLA Health reveals that women continue to face barriers in accessing lung transplants compared to men, ...
Results from the first randomized controlled trial to directly compare the safety and efficacy of cutting balloon (CB) ...
Comparable overall survival seen at seven and 10 years, lung cancer-specific survival, and recurrence-free survival.
SAN ANTONIO, October 07, 2025--(BUSINESS WIRE)--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company advancing noninvasive diagnostics for lung cancer and other lung diseases, ...
Biological therapy was associated with significant changes in lung structure and, by extension, improved lung function in individuals with chronic obstructive pulmonary disease (COPD) and T2 ...
Anastasia “Stassie” Karanikolaou is keeping it real with fans, detailing her recovery process after going under the knife to reverse the results of her BBL surgery. The influencer, 28, shared an ...
Hosted on MSN
Why more women are choosing breast reduction surgery
"GMA" explores the growing trend among young women opting for breast reductions and what's driving the change. Walmart deploys millions of new sensors in retail's first large-scale deployment of IoT ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback